Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

LIPOPROTEIN ( A )

Devices (same UDI-DI)
1
Certificates
0
Countries
6
Notified Bodies
0

Basic Information

Primary DI
06975225463685
Basic UDI-DI Code
B-06975225463685
Reference
DTSH030704
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

"The kit is intended for the in vitro quantitative determination ofα1-microglobulin (α1-MG) in human urine and is mainly used in the auxiliary diagnosis of renal tubule damage clinically. α1-MG is a small molecule glycoprotein with a carbohydrate composition of about 20% carbohydrate and relative molecular weight of 30-33 kDa. It is mainly synthesized in the liver and lymphocytes. Under normal conditions, α1-MG in the blood can freely pass through the glomerulus, and about 99.9% are reabsorbed and metabolized in proximal convoluted tubules, with only trace amounts excreted out of the body. When the renal tubular function is impaired, the reabsorption and metabolism of α1-MG are reduced, and the α1-MG level in the urine is increased. Therefore, urine α1-MG can be used as an effective indicator of renal tubule damage "

CND Nomenclature Codes

Code Description
W0102010405 LIPOPROTEIN ( A )

Available In Countries

🇧🇪 Belgium 🇩🇪 Germany 🇫🇷 France 🇮🇹 Italy 🇳🇱 Netherlands 🇸🇪 Sweden

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all